secwatch.observer — SEC 8-K summary
======================================

Issuer:     Inmune Bio, Inc. (INMB)
CIK:        0001711754
Form:       8-K
Filed at:   2025-05-14T23:59:59+00:00
Accession:  0001213900-25-043270
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

INmune Bio to present at RBC Capital Markets Global Healthcare Conference on May 20-21
--------------------------------------------------------------------------------

- Fireside chat and 1-on-1 virtual meetings on May 20-21, 2025, at InterContinental Barclay NY.
- Presentation at 11:00am EDT; no material financial or pipeline updates announced.
- Clinical-stage biotech targeting innate immune system with three product platforms.
- No new clinical data, partnerships, or financial disclosures in the release.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1711754/000121390025043270/0001213900-25-043270-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1711754/000121390025043270/ea0242053-8k_inmune.htm
  HTML page:      https://secwatch.observer/filing/0001213900-25-043270

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer